- 2023 - 2028 Metabolic regulation of reproductive lifespan
- 2023 - 2028 Usefulness of metabolite biomarker as a common pathway for the prevention of non-communicable diseases and frailty
- 2022 - 2025 神経膠腫におけるがん代謝を標的とした治療法の開発
- 2022 - 2025 間葉系幹細胞カラムとiPS細胞・遺伝子編集技術を融合した新規治療システム
- 2021 - 2024 間葉系幹細胞の微小環境での炎症制御機構に着眼した次世代型免疫・炎症制御法の創成
- 2021 - 2024 フルクトース代謝を標的とした糖尿病性腎臓病の病態解明と新規治療法の開発
- 2020 - 2023 Renal plasma flow (RPF) and accurate GFR equations utilizing metabolomics analysis
- 2019 - 2022 Elucidation of the mechanism of tumorigenesis and development of new treatments using iPS cell-derived mutant IDH glioma model
- 2018 - 2022 Multistep carcinogenesis mechanism of renal cell carcinoma using human iPS cell-derived nephron induction and development of therapeutic platform
- 2018 - 2021 Development of integrated treatment for impaired liver regeneration on non-alcoholic steatohepatitis
- 2018 - 2021 Development of renal disease type screening method for clinical application
- 2018 - 2020 がん細胞の飛び道具「エクソソーム」のトランスオミクス解析
- 2015 - 2019 Metabolome-wide metabolic profiling and non-communicable disease prevention in a population-based cohort study
- 2015 - 2018 Development of a novel diagnosis marker for kidney diseases by metabolome analysis
- 2013 - 2016 Development of novel diagnosis method for renal desease using metabolome analysis
- 2012 - 2016 Integrated analysis and detection of new therapeutic target aimed for improvement of prognosis in the patients with pancreatic malignant neoplasms
- 2014 - 2015 Epidemiological study of prevention biomarker for mood and anxiety disorder by CE/MS based metabolimics
- 2013 - 2015 Elucidation of pancreatic cancer specific metabolism and biomarker discovery using metabolomics
- 2010 - 2015 Understanding cancer cell metabolism and biomarker discovery using metabolome analysis
Show all